<DOC>
	<DOCNO>NCT00611936</DOCNO>
	<brief_summary>A total 18 healthy volunteer participate four-week , within-groups , double-blind , placebo-controlled study . The study two phase separate 4 15-day washout period . Subjects randomly assign receive either 40 mg atomoxetine placebo . For Phase I , subject assign atomoxetine placebo 4 day . After receive medication placebo three day , subject 6-hour laboratory session , responses physical psychological stress 20 mg/70 kg ( 20 mg maximum ) dose d-amphetamine measure . Several physiological , hormonal , subjective outcome measure obtain experimental session . Subjects 4-15 day washout period cross alternative treatment Phase II .</brief_summary>
	<brief_title>Effects Atomoxetine Treatment Humans</brief_title>
	<detailed_description>Objective : This pilot study examine effect norepinephrine reuptake blocker , atomoxetine , physiological subjective response physical psychological model stress oral amphetamine healthy volunteer . The physical stress model cold pressor test ( CPT ) psychological stress pace auditory serial addition task ( PASAT ) . Our overall hypothesis atomoxetine treatment , compare placebo , attenuate physiological subjective response stress d-amphetamine . 2 . Research Design : Double-blind , placebo-controlled , within-groups , outpatient study . 3 . Methodology : A total 18 healthy volunteer participate four-week , within-groups , double-blind , placebo-controlled study . The study two phase separate 4 15-day washout period . Subjects randomly assign receive either 40 mg atomoxetine placebo . For Phase I , subject assign atomoxetine placebo 4 day . After receive medication placebo three day , subject 6-hour laboratory session , responses physical psychological stress 20 mg/70 kg ( 20 mg maximum ) dose d-amphetamine measure . Several physiological , hormonal , subjective outcome measure obtain experimental session . Subjects 4-15 day washout period cross alternative treatment Phase II . 4 . Findings : A total 10 subject complete study . This study publish .</detailed_description>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<criteria>Female male , age 18 45 year Current history good health normal ECG For woman : pregnant determine pregnancy screening , breast feeding , use acceptable birth control method . History heart disease , hypertension , renal hepatic disease , glaucoma , hyperthyroidism , medical condition physician investigator deems contraindicate patient study Current use psychotropic medication ( antidepressant , antipsychotic , anxiolytic ) and/or diagnosis treatment Axis I disorder include major depression , bipolar affective disorder , schizophrenia panic disorder within past year . Current dependence alcohol drug treatment drug alcohol addiction ( amphetamine great abuse liability among drug addiction ) within past 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Atomoxetine</keyword>
	<keyword>Stress</keyword>
	<keyword>d-amphetamine</keyword>
</DOC>